Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaolong Tang

Showing results (1-10 of 309) with videos related to

Pageof 31
Sort By:
American Journal of Translational Research|March 14, 2023
ETS-1/c-Met drives resistance to sorafenib in hepatocellular carcinomaYongfang Ma, Xueke Liu, Xiaolong Tang
Heliyon|January 23, 2023
Immune checkpoint PTPN2 predicts prognosis and immunotherapy response in human cancersXiaolong Tang, Xue Sui, Yongshuo Liu
Disease Markers|January 30, 2023
High Expression of DLGAP5 Indicates Poor Prognosis and Immunotherapy in Lung Adenocarcinoma and Promotes Proliferation through Regulation of the Cell CycleXiaolong Tang, Honghong Zhou, Yongshuo Liu
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 28, 2023
STUB1/CHIP: New insights in cancer and immunityYongshuo Liu, Honghong Zhou, Xiaolong Tang
Histology and Histopathology|April 9, 2024
Chondroitin polymerizing factor (CHPF) promotes the progression of colorectal cancer through ASB2-mediated ubiquitylation of SMAD9Jiang Zhao, Xiaolong Tang, Huijun Zhu
Physiological Reviews|September 7, 2023
SIRT7: the seventh key to unlocking the mystery of agingUmar Raza, Xiaolong Tang, Zuojun Liu, et al.
Frontiers in Oncology|August 12, 2022
Critical roles of PTPN family members regulated by non-coding RNAs in tumorigenesis and immunotherapyXiaolong Tang, Chumei Qi, Honghong Zhou, et al.
Integrative Zoology|March 18, 2021
Tail display is regulated by anaerobic metabolism in an Asian agamid lizardXinxin Zhu, Xia Qiu, Xiaolong Tang, et al.
Iscience|March 25, 2024
Analysis and prediction in SCR experiments using GPT-4 with an effective chain-of-thought prompting strategyMuyu Lu, Fengyu Gao, Xiaolong Tang, et al.
Journal of Biomedical Nanotechnology|June 18, 2022
Nanoparticles Loaded with GSK1059615 Combined with Sorafenib Inhibited Programmed Cell Death 1 Ligand 1 Expression by Negatively Regulating the PI3K/Akt/NF-<i>κ</i>B Pathway, Thereby Reversing the Drug Resistance of Hepatocellular Carcinoma to SorafenibShuping Zhou, Yongfang Ma, Ruyue Xu, et al.
Pageof 31

Showing results (1-10 of 309) with videos related to

Sort By:
Pageof 31
American Journal of Translational Research|March 14, 2023
ETS-1/c-Met drives resistance to sorafenib in hepatocellular carcinomaYongfang Ma, Xueke Liu, Xiaolong Tang
Heliyon|January 23, 2023
Immune checkpoint PTPN2 predicts prognosis and immunotherapy response in human cancersXiaolong Tang, Xue Sui, Yongshuo Liu
Disease Markers|January 30, 2023
High Expression of DLGAP5 Indicates Poor Prognosis and Immunotherapy in Lung Adenocarcinoma and Promotes Proliferation through Regulation of the Cell CycleXiaolong Tang, Honghong Zhou, Yongshuo Liu
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 28, 2023
STUB1/CHIP: New insights in cancer and immunityYongshuo Liu, Honghong Zhou, Xiaolong Tang
Histology and Histopathology|April 9, 2024
Chondroitin polymerizing factor (CHPF) promotes the progression of colorectal cancer through ASB2-mediated ubiquitylation of SMAD9Jiang Zhao, Xiaolong Tang, Huijun Zhu
Physiological Reviews|September 7, 2023
SIRT7: the seventh key to unlocking the mystery of agingUmar Raza, Xiaolong Tang, Zuojun Liu, et al.
Frontiers in Oncology|August 12, 2022
Critical roles of PTPN family members regulated by non-coding RNAs in tumorigenesis and immunotherapyXiaolong Tang, Chumei Qi, Honghong Zhou, et al.
Integrative Zoology|March 18, 2021
Tail display is regulated by anaerobic metabolism in an Asian agamid lizardXinxin Zhu, Xia Qiu, Xiaolong Tang, et al.
Iscience|March 25, 2024
Analysis and prediction in SCR experiments using GPT-4 with an effective chain-of-thought prompting strategyMuyu Lu, Fengyu Gao, Xiaolong Tang, et al.
Journal of Biomedical Nanotechnology|June 18, 2022
Nanoparticles Loaded with GSK1059615 Combined with Sorafenib Inhibited Programmed Cell Death 1 Ligand 1 Expression by Negatively Regulating the PI3K/Akt/NF-<i>κ</i>B Pathway, Thereby Reversing the Drug Resistance of Hepatocellular Carcinoma to SorafenibShuping Zhou, Yongfang Ma, Ruyue Xu, et al.
Pageof 31